Tiba scientists are working with our academic collaborators at the University of Pittsburg and Carnegie Mellon University to design a new approach to mRNA vaccine delivery. The combined stability of our nanoparticles and the dosing efficiency of a micro-needle patch offer new opportunities for healthcare professionals in resource-limited settings.